Cytokine-secreting cells from mice immunized with TNFQ11 combined with the
indicated doses of T-cell epitope (PADREQ11 or VACQ11) were quantified ex
vivo by ELISPOT after re-stimulation of lymph node cell suspensions with
peptide TNF, peptide PADRE (a, b) or peptide VAC (c, d). In a–b, for the various
PADREQ11 contents (0, 0.002, 0.01, 0.05, 0.25, and 0.75 mM) group sizes were 2, 3, 4, 3,
4, and 4 mice, respectively. c–d represent a combination of two independently
conducted experiments, where sample sizes for each group were 3 mice (data in the figure
shows these two experiments together, with a total sample size of 6 mice per group). Mean
± SD is shown. Statistical significance was tested by two way ANOVA with
Tukey’s multiple comparison test. Significance found between T and B-cell epitope
stimulation at each T-cell epitope concentration is denoted. *p<0.05,
**p<0.01, and ***p<0.001.